Orchestra Biomed Secures $70M Strategic Investment
Orchestra Biomed Secures $70M in Strategic Funding, Expanding Cardiovascular Pipeline and Partnerships Orchestra Biomed has secured $70 million in...
Orchestra Biomed Secures $70M in Strategic Funding, Expanding Cardiovascular Pipeline and Partnerships Orchestra Biomed has secured $70 million in...
Poltreg Secures FDA Support for Registrational Trial in Pre-Symptomatic Type 1 Diabetes Poltreg, a Polish biotech specializing in T-regulatory...
Supernus Pharmaceuticals has finalized its acquisition of Sage Therapeutics, marking a significant shift in the CNS treatment landscape. This...
VedtechBio Research Pvt. Ltd. has significantly enhanced its AI-driven drug discovery platform, RxAgentAIâ„¢, claiming a halving of drug development...
Artelo Biosciences has secured positive scientific advice from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its...
Orchestra Biomed Secures $70M in Strategic Funding, Signaling Growing Confidence in Late-Stage Cardiology Programs Orchestra Biomed has secured $70...
Bio Usawa and Sartorius Stedim Biotech Forge Partnership to Bolster Africa’s Biopharma Capabilities Bio Usawa, a Rwandan biotechnology company,...
Sandoz’s proposed acquisition of Just-Evotec Biologics (JEB) for approximately $300 million marks a significant move to solidify its position...
Cardiff Oncology Reports Promising Phase 2 Onvansertib Data in RAS-Mutated Metastatic Colorectal Cancer Cardiff Oncology has unveiled positive interim...
Cardiff Oncology, a clinical-stage biotech focusing on PLK1 inhibition in cancer treatment, recently completed enrollment in its crucial Phase...